Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distribution agreement with KomaBiotech, a Korean manufacturer and supplier of reagents and tools for life science research, to market, distribute and support the Anteo Mix&Go (AMG) products in South Korea.
"Having a partner like Koma in South Korea which is expert in sales, marketing and the provision of quality customer support is important for Anteo. Since the AMG range is relatively new, having representatives on the ground who can ensure customers are getting the most from the products is the greatest way to deliver best adoption practices. Under this agreement, Koma will ensure that support, training and service is delivered appropriately," finished Dr Cumming.
Ms KJ Sohn, general manager, Koma commented, "Anteo products are excellent tools for researchers who are developing multiplexing kits, due to their ability to increase sensitivity and consistency when coupling a broad range of molecules."